Research Reports
- 4/12/2024
Tecarfarin Receives Orphan Drug Designation For Second Indication
- 3/13/2024
FY2023 Reported With Continued Progress Toward The Phase 3 Tecarfarin Trial
- 2/1/2024
Peer-Reviewed Journal Reviews Uses of DOAC Drugs, Pointing To The Need For Tecarfarin
- 12/18/2023
Addressing Unmet Anticoagulation Needs In Orphan Populations